Loading company…
SecondWave develops wearable ultrasound devices for noninvasive therapeutic stimulation.
SecondWave develops wearable devices that use low-intensity focused ultrasound to modulate nerves, cells and organs. Its technology targets conditions including inflammation and pain, with a design for in-home use. Founded in 2019, the company is based in Minneapolis, US. In April 2025, it raised USD 7.000 mn in Series A funding from Treo Ventures, Scientific Health Development and the University of Minnesota.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in